Corcept Therapeutics (CORT) PT Raised to $130 at Canaccord Genuity
Tweet Send to a Friend
(Updated - January 30, 2025 6:27 AM EST)
Canaccord Genuity analyst Edward Nash raised the price target on Corcept ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Edward Nash raised the price target on Corcept ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
